Loading
A positive leftover-cancer blood test leaves patients frightened and their doctors unsure what to do. A specialist clinic could give them a plan and a trial.
The molecular relapse population is growing fast and falls between services: no visible disease, no standard therapy, high anxiety and low trial awareness. A named clinic (confirmatory retesting, sensitive imaging, psychological support, trial screening and structured follow-up) is a service-design intervention that could be evaluated like any other pathway.
Shares Patients lack understanding, navigation and agency, Fragmented care and guideline gaps.
Shares AI trial matching & clinical decision support, Patients lack understanding, navigation and agency.
Shares Dormant cells and minimal residual disease, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing.
Shares Dormant cells and minimal residual disease, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing.
Shares AI trial matching & clinical decision support, Patients lack understanding, navigation and agency.
Shares Patients lack understanding, navigation and agency, Fragmented care and guideline gaps.
Shares Dormant cells and minimal residual disease, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing.
Shares Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/